In this presentation, Dr. Jonathan Meyer discusses whether it is safe to use psychotropics in patients with hepatic issues, such as steatosis, cirrhosis, and hepatitis C. He also guides clinicians on assessing liver function and the utility and interpretation of the Child-Pugh scale. Finally, he presents a clinical vignette to assess valproate safety in patients with hepatitis C and when to adjust the dose.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-2582?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-04-01 05:00:00
- End Date: 2022-04-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest